Literature DB >> 2445126

Serotyping of Aeromonas species using passive haemagglutination.

P A Guinée1, W H Jansen.   

Abstract

Antisera were raised with heat-killed vaccines prepared from 25 Aeromonas hydrophila strains, 4 A. sobria strains and one A. caviae strain. Twenty-seven of these 30 antisera gave high titers when tested in the microtiter tray agglutination (MTA) test with their homologous antigen heated at 100 degrees C for 30 min. Three O antisera gave low titers in the MTA test but reacted to high titers in the haemagglutination (HA) test with conserved sheep red blood cells coated with alkali-treated heat extract. All 27 antisera showing high titers in the MTA test, showed even higher titers in the HA test. Therefore, the HA technique was employed to type 306 strains isolated from surface and drinking water, from food samples and from faeces of human patients with diarrhea. Of 155 A. hydrophila strains 21 (14%) could not be typed. For A. sobria and A. caviae, the percentage of untypable strains was 46% and 68% respectively. Many A. sobria and A. caviae strains reacted to titer in A. hydrophila O antisera. A limited number of strains reacted to titer in more than one specific O antiserum. Immunoelectrophoretic studies indicated that the O antigen is often represented by more than one precipitation line and that true K antigens occur in Aeromonas.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2445126     DOI: 10.1016/s0176-6724(87)80248-1

Source DB:  PubMed          Journal:  Zentralbl Bakteriol Mikrobiol Hyg A        ISSN: 0176-6724


  2 in total

1.  Comparison of two O-serogrouping systems for mesophilic Aeromonas spp.

Authors:  T Shimada; Y Kosako
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

2.  Pathogenic Aeromonas hydrophila serogroup O:14 and O:81 strains with an S layer.

Authors:  Consuelo Esteve; Elena Alcaide; Rocío Canals; Susana Merino; Dolores Blasco; Maria José Figueras; Juan M Tomás
Journal:  Appl Environ Microbiol       Date:  2004-10       Impact factor: 4.792

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.